Skip to content

Investors

This company is capitalized  by  Innvierte, an investment program of  CDTI, E.P.E.  ema innovador de Ablación por Radio-Frecuencia guiado por Imagen para ión .


Ablaview - Un sistema innovador de Ablación por Radio-Frecuencia guiado por Imagen para el Tratamiento de la Fibrilación Auricular.  RTC-2016-5445-1 Retos Colaboración 2016.


© MedLumics 2019
Contact
Legal Notice
Privacy Policy
Cookies Policy

This site is intended for Healthcare professionals only. MedLumics S.L. is a pre-commercial, medical device company that designs and manufactures catheter-based systems for the treatment of supra-ventricular tachycardias. MedLumics products are currently for investigation purposes and are intended to be used by trained professionals. MedLumics is committed to transform progress in the science and technology of light into high-quality innovative products improving human living standards worlwide.

MedLumics uses cookies which are necessary for the proper functioning of its websites, to optimize the functionality of the site and ensure that we give the best user experience. Medlumics only use qtrans_cookie to enable multi-lingual support. Click "Agree and proceed" to accept cookies and go directly to our site or click on "Read more" to see our cookie policy in detail. By continuing to use this site you are giving us your consent to use this cookie.

MedLumics
Powered by  GDPR Cookie Compliance
Privacy Overview

MedLumics uses cookies which are necessary for the proper functioning of its websites, to optimize the functionality of the site and ensure that we give the best user experience.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.